Drug intelligence / Profile preview

HYR04

Development stage
Unknown
Lead developer
Tiandi Hengyi Pharmaceutical
Administration
Oral
01

Overview

HYR04 is a traditional Chinese medicine (TCM) capsule developed by Tiandi Hengyi for the treatment of knee osteoarthritis, specifically targeting patients with the cold-dampness obstruction pattern (寒湿痹阻证). Registered as a Class 2.3 TCM modified new drug in China, HYR04 is a clinical-stage development of the company's marketed Huoluo Xiaotong capsule (活络消痛胶囊), which is formulated from a mixture of ten herbal ingredients including Acanthopanax senticosus extract, Clematis chinensis, Angelica sinensis, processed Aconitum carmichaelii, processed Aconitum kusnezoffii, Ephedra sinica, Anemone raddeana, Salvia miltiorrhiza, processed Boswellia carterii, and processed Commiphora myrrha. HYR04 is currently undergoing Phase II clinical evaluation in China to assess its efficacy in improving knee pain and joint function.

Other names
Huoluo Xiaotong capsule活络消痛胶囊

Beyond the preview

Go deeper on HYR04.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HYR04.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call